Jupiter Medical Center selects IBM Watson for Oncology platform
US-based Jupiter Medical Center has selected IBM cognitive computing platform, which will enable oncologists to take cancer treatment decisions.
IBM Watson for Oncology platform will offer insights to physicians to provide personalized and evidence-based cancer treatment for the patients.
Jupiter is planning to start the implementation of the new cognitive computing platform at the facility in the beginning of March.
The cognitive computing platform will analyze massive volumes of medical literature to identify individualized treatment options.
The platform takes the information from more than 200 textbooks and nearly 15 million pages of text to provide insights about various treatment options.
It will also offer oncologists with information regarding drug options and administration instructions.
In addition, the platform ranks the evidence-based treatment options based on peer reviewed studies and clinical guidelines.
Jupiter Medical Center president and CEO Dr John Couris said: “Watson for Oncology is part of our significant investment in creating a world-class cancer program and we are proud to be the first U.S. community hospital to arm our clinical team with this cutting-edge technology.”
IBM Watson Health oncology and genomics vice president Rob Merkel said: “In communities across the country and around the world, there is a growing need for tools that help increase efficiency and enable quick access to important information from the collective body of cancer knowledge available today.”
Located in Florida, Jupiter Medical Center has 207 private acute-care hospital beds and 120 long-term care, sub-acute rehabilitation and gospice beds.
It provides a range of services, including cardiology, oncology, imaging, orthopedics and spine, digestive health, emergency services and others.
Image: Jupiter Medical Center oncology chief Dr Abraham Schwarzberg, reviews recommendations generated by IBM Watson for Oncology. Photo: courtesy of Flickr / IBM.